IPO - Incannex Healthcare Inc.

Form Type: S-1/A

Filing Date: 2025-04-16

Corporate Action: Ipo

Type: New

Accession Number: 000121390025032577

Filing Summary: This filing is Amendment No. 1 to Form S-1 for Incannex Healthcare Inc., presented to the SEC on April 16, 2025, which converts a prior registration statement on Form S-3 into a registration statement on Form S-1. The prospectus outlines the offering of 75,902,171 shares of Common Stock, initiated by selling stockholders, detailing both pre-funded warrants and Series A warrants for potential issuance of additional stock. As of the date noted, the company's shares are actively traded on Nasdaq, reflecting a closing sale price of $0.629 per share. The document emphasizes the company's commitment to biopharmaceutical research, focusing on treatments for chronic conditions, and notes that the company is classified as both an emerging growth and a smaller reporting company, subject to reduced public reporting requirements. Specific risks associated with investment are presented, highlighting potential volatility in share prices due to extensive stock offerings.